Literature DB >> 8910099

Obesity, adiposity, and lengthening of the QT interval: improvement after weight loss.

M J Carella1, S L Mantz, D R Rovner, P W Willis, V V Gossain, R R Bouknight, G S Ferenchick.   

Abstract

OBJECTIVES: To determine the prevalence of QT interval prolongation in patients referred to an outpatient clinic for treatment of obesity; and to describe the change in the QT interval during rapid weight loss with a very-low-calorie diet.
DESIGN: Retrospective and prospective review of charts and electrocardiograms.
SUBJECTS: Five hundred twenty-two obese patients (411 female, 112 males) with a mean age 44 (18-78 y) and a mean initial weight of 116 kg (63-285 kg) completing 26 weeks of treatment between September, 1989 through to December, 1993. MEASUREMENTS: We reviewed the EKGs of all patients and serially monitored the QTc if greater than 0.44 s or if more than 23 kg was lost during treatment. The QTc interval was calculated with Bazzett's formula using both a manual method and an automated software program. In some patients, body composition was measured by hydrodensitometry.
RESULTS: The QTc interval before treatment was 0.42 +/- 0.026 s by manual measurement and 0.41 +/- 0.021 s by automated measurement. Forty-one to 53% of patients showed a QTc interval of greater than 0.42 s and 10-24% demonstrated moderate prolongation (> 0.44 s). In those patients for whom repeat EKG were performed, QTc showed shortening with weight loss by both methods (mean +/- s.e. of 0.42 +/- 0.003 to 0.41 +/- 0.003 s, P < 0.01 manually and 0.41 +/- 0.003 to 0.40 +/- 0.003 s, p < 0.005 by automated program). Analyses were repeated excluding 179 patients with a cardiovascular-related diagnosis or intraventricular block and the results were similar. By regression analysis, gender and fat mass (FM) percentage above normal predicted the QTc.
CONCLUSIONS: QT Interval prolongation is common in obesity. For each 50% increase in FM% above normal, there is a 5 ms increase in the QTc above a 'normal' upper limit of 0.40 and 0.38 s in women and men, respectively. Moreover, the QT interval shortens with weight loss. This change may represent an additional benefit of weight loss along with the improvement in other cardiovascular risk factors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910099

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  15 in total

1.  Familial aggregation and heritability of electrocardiographic intervals and heart rate in a rural Chinese population.

Authors:  Jianping Li; Yong Huo; Yan Zhang; Zhian Fang; Jianhua Yang; Tonghua Zang; Xiping Xu; Xin Xu
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-04       Impact factor: 1.468

Review 2.  Antipsychotic agents and QT changes.

Authors:  R Welch; P Chue
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

3.  QT Interval Shortening After Bariatric Surgery Depends on the Applied Heart Rate Correction Equation.

Authors:  Erik K Grasser; Barbara Ernst; Martin Thurnheer; Bernd Schultes
Journal:  Obes Surg       Date:  2017-04       Impact factor: 4.129

Review 4.  Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation.

Authors:  Vladimir Piotrovsky
Journal:  AAPS J       Date:  2005-10-24       Impact factor: 4.009

5.  Shortening of the QT interval is observed soon after sleeve gastrectomy in morbidly obese patients.

Authors:  Abdallah Al-Salameh; Jennifer Allain; Aurelie Jacques; Pierre Verhaeghe; Rachel Desailloud
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

6.  Association between C-reactive protein and QTc interval in middle-aged men and women.

Authors:  Eunhee Kim; SoonJae Joo; Jinyoung Kim; JeongCheon Ahn; JeHyeong Kim; Kuchan Kimm; Chol Shin
Journal:  Eur J Epidemiol       Date:  2006-10-27       Impact factor: 8.082

Review 7.  Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

Authors:  Peter M Haddad; Ian M Anderson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

8.  P-wave duration and dispersion in obese subjects.

Authors:  Feridun Kosar; Yüksel Aksoy; Fahri Ari; Lezzan Keskin; Ibrahim Sahin
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-01       Impact factor: 1.468

Review 9.  QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review.

Authors:  Mehrul Hasnain; W Victor R Vieweg
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

10.  Different body parts' fat mass and corrected QT interval on the electrocardiogram: The Fasa PERSIAN Cohort Study.

Authors:  Mohammad Hosein Yazdanpanah; Ehsan Bahramali; Mohammad Mehdi Naghizadeh; Mojtaba Farjam; Maryam Mobasheri; Shiva Dadvand
Journal:  BMC Cardiovasc Disord       Date:  2021-06-05       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.